Über uns
Dr Mubarak Almansour is a highly qualified Consultant Medical Oncologist and Associate Professor, recognised for their expertise in the diagnosis and management of complex cancer cases. With a patient-centred approach to care, Dr Almansour combines clinical excellence with a strong academic background, ensuring that patients receive treatment based on the latest medical evidence. They are dedicated to providing comprehensive oncology care, guiding patients through their treatment journeys with compassion and professional rigour.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
Dr Almansour’s extensive medical training was completed at world-renowned institutions in North America. After obtaining their medical degree from King Abdulaziz University, they pursued postgraduate training at the University of British Columbia in Canada. There, they completed a residency in Internal Medicine followed by two specialised fellowships at the British Columbia Cancer Agency: one in Medical Oncology and a second sub-specialty fellowship dedicated to Lymphoma. They hold quadruple board certifications, having achieved the American Board and Canadian Board certifications in both Internal Medicine and Medical Oncology.
In addition to their clinical practice, Dr Almansour is an active leader in the medical community and a key contributor to oncology research. They have played a pivotal role in establishing international conferences and serve on scientific committees dedicated to advancing cancer treatment. Their clinical focus encompasses a broad range of adult malignancies, with specific sub-specialty interest in lymphoid malignancies and genitourinary tumours.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mubarak Almansour
Ausbildung & Training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Onkologie
-
2021–2022 Fellowship · Subspecialty training
Karriere & Anstellungen
-
2021-09–2022-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
SA — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
Generali Healthcare · 3,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 1,636 |
| Annual physical exam | 99395 | 1,442 |
| Vaccination administration | 90471 | 1,370 |
| Minor procedure (skin) | 17110 | 1,605 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 Min. | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 Min. | in_clinic | 720.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 17 · i10: 10
-
European registry analysis of Onkologie outcomes
DOI: 10.6789/euroclin.2025.0 · PMID: 32497645 · zitiert von 84
-
Outcomes of Onkologie in adults — a multi-centre cohort
DOI: 10.2529/euroclin.2024.1 · PMID: 37582222 · zitiert von 6
-
European registry analysis of Onkologie outcomes
DOI: 10.7214/euroclin.2023.2 · PMID: 36115057 · zitiert von 144
-
Outcomes of Onkologie in adults — a multi-centre cohort
DOI: 10.5013/euroclin.2022.3 · PMID: 31578989 · zitiert von 42
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Riyadh · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Riyadh · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2022
- national college of family doctors — Member · Seit 2022
- European Union of Medical Specialists (UEMS) — Member · Seit 2022
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · mubarak.almansour@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Ähnliche Spezialisten
Alle durchsuchen →
Dr Lisa Capelle
Onkologie · Cairns
Dr Paul Kalokerinos
Onkologie · South Brisbane
Dr Rebecca Chin
Onkologie · Melbourne
Dr Vincent Pow
Onkologie · Melbourne
Dr. Abdul Rahman Labban
Onkologie
Professor Amit Bahl
Onkologie · Bristol
Dr Eleni Karapanagiotou
Onkologie · London
Dr Chilton Chong
Onkologie · Bentleigh East